Post

Fungal Disease Awareness Week: novel drugs essential to tackle antifungal resistance

18-22 September is Fungal Disease Awareness Week (FDAW) in the US, in which the Centers for Disease Control and Prevention …

Signal: UK NHS pay row intensifies as doctors launch joint strike

UK consultants and junior doctors walked out today (20 September) for joint strike action, the first in the National Health …

Medidata unveils new solution to boost clinical trial diversity

Medidata has unveiled a new solution called the Medidata Diversity Program, which aims to enhance diversity, equity, and inclusion in …

Taysha suspends its lead gene therapy programme after FDA feedback

Taysha Gene Therapies has discontinued its TSHA-120 development for gene therapy following a Type C meeting with the US Food …

1ST Biotherapeutics and Merck to assess cancer combination treatment

1ST Biotherapeutics has signed a clinical trial collaboration and supply agreement with Merck & Co (MSD) to assess FB849 plus Keytruda (pembrolizumab) …

Relmada reports positive results from trial of MDD therapy

Relmada Therapeutics has reported positive safety and efficacy results from the long-term Phase III REL-1017-310 trial evaluating REL-1017 in patients …

Signal: Fresh Tracks nears end of operations with plans for dissolution

Fresh Tracks Therapeutics has announced a proposed dissolution and liquidation of the company in “an orderly fashion” as stated by …

Vir Biotechnology doses first subject in HIV therapy trial

Vir Biotechnology has dosed the first patient in the Phase I HVTN 142 clinical trial of the new T cell …

Regulus reports positive Phase Ib data for kidney disease treatment

Regulus Therapeutics has reported positive topline data from the first cohort of its Phase Ib multiple-ascending dose (MAD) clinical trial of RGLS8429 …

Will there ever be a cure for Alzheimer’s disease?

It has been over 100 years since Dr Alois Alzheimer reported “a peculiar severe disease process of the cerebral cortex” …